Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.
Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedDeciphera Pharmaceuticals, LLC has been updated from version v2.10.0 to v2.10.2.SummaryDifference0.2%
- Check51 days agoChange DetectedThe study has expanded to include 121 locations, and the website has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.2%
- Check58 days agoChange DetectedThe website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.SummaryDifference0.1%
- Check72 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check77 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the content on the webpage.SummaryDifference0.1%
Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.